CBDS Stock Overview
Cannabis Sativa, Inc., through its subsidiaries, primarily provides telemedicine online referral services for customers desiring medical marijuana cards in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Cannabis Sativa, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.018 |
| 52 Week High | US$0.055 |
| 52 Week Low | US$0.0012 |
| Beta | 1.44 |
| 1 Month Change | 39.62% |
| 3 Month Change | 12.80% |
| 1 Year Change | -65.23% |
| 3 Year Change | -97.15% |
| 5 Year Change | -99.18% |
| Change since IPO | -97.39% |
Recent News & Updates
Recent updates
Shareholder Returns
| CBDS | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 23.3% | 4.2% | -3.7% |
| 1Y | -65.2% | 2.5% | 20.2% |
Return vs Industry: CBDS underperformed the US Healthcare industry which returned 0.8% over the past year.
Return vs Market: CBDS underperformed the US Market which returned 20.5% over the past year.
Price Volatility
| CBDS volatility | |
|---|---|
| CBDS Average Weekly Movement | 32.5% |
| Healthcare Industry Average Movement | 7.2% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: CBDS's share price has been volatile over the past 3 months.
Volatility Over Time: CBDS's weekly volatility (32%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 6 | David Tobias | n/a |
Cannabis Sativa, Inc., through its subsidiaries, primarily provides telemedicine online referral services for customers desiring medical marijuana cards in the United States. The company offers PrestoDoctor, an online telemedicine platform, which provides access to physicians for getting a medical marijuana recommendation using video conferencing technology. Its products under development include Lozenges for relief from throat irritation; Recover, a deep penetrating healing balm used to relieve pain for sore muscles, joints, arthritic, and back pain; Trauma Cream, a cream for blended infusion of cannabinoids and THC; Face Garden, an antioxidant moisturizing cream for the face; Body Garden, a moisturizing body lotion; and Lip Garden, an emollient balm.
Cannabis Sativa, Inc. Fundamentals Summary
| CBDS fundamental statistics | |
|---|---|
| Market cap | US$1.51m |
| Earnings (TTM) | -US$1.70m |
| Revenue (TTM) | US$1.24m |
1.3x
P/S Ratio-1.0x
P/E RatioIs CBDS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CBDS income statement (TTM) | |
|---|---|
| Revenue | US$1.24m |
| Cost of Revenue | US$447.15k |
| Gross Profit | US$788.51k |
| Other Expenses | US$2.49m |
| Earnings | -US$1.70m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.019 |
| Gross Margin | 63.81% |
| Net Profit Margin | -137.68% |
| Debt/Equity Ratio | 32.0% |
How did CBDS perform over the long term?
See historical performance and comparison